FRANKLIN LAKES, N.J., May 12, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. launch of its new, fully ...

FRANKLIN LAKES, N.J., Dec. 17, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has expanded the BD COR™ System to ...

The BD COR MX/PX System integrates and automates the complete molecular laboratory workflow, from sample processing to diagnostic test result for large, high-throughput labs. – BD Becton, Dickinson ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced the launch of BD COR System, a new and fully-automated high-throughput diagnostic system utilizing robotics and sample ...

Becton, Dickinson and Company BDX, also popularly known as BD, recently introduced its new fully-automated, high-throughput infectious disease molecular diagnostics platform in the United States. With ...

As the science and technology behind genomic sequencing progresses, high-throughput molecular testing has increasingly become a crucial tool in identifying diseases in their earliest stages. Despite ...

FRANKLIN LAKES, N.J., May 26, 2022 / B3C newswire / --BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new high-throughput molecular ...

BD (Becton, Dickinson and Company), a leading global medical technology company, announced the US launch of its new, fully automated, high-throughput infectious disease molecular diagnostics platform.